Neuphoria Therapeutics Inc. Trade And Other Current Payables To Trade Suppliers
Neuphoria Therapeutics Inc. (NEUP) had Trade And Other Current Payables To Trade Suppliers of AUD 2.06 million as of 2023-06-30, per its 20-F filed 2023-10-18.
Discontinued › Notes
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers · last filed 2023-10-18
- 2023-06-30: Trade And Other Current Payables To Trade Suppliers 2.06M AUD.
- 2022-06-30: Trade And Other Current Payables To Trade Suppliers 1.56M AUD.
- 2021-06-30: Trade And Other Current Payables To Trade Suppliers 1.03M AUD.
| Period end | Trade And Other Current Payables To Trade Suppliers |
|---|---|
| 2023-06-30 | 2.06M AUD 20-F · filed 2023-10-18 |
| 2022-06-30 | 1.56M AUD 20-F · filed 2023-10-18 |
| 2021-06-30 | 1.03M AUD 20-F · filed 2022-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |